Mink Therapeutics
phase clinical trial focused in induced | Mink Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
October 2021
Slide
36 of 36
Related slides by other companies
Graphite Bio
IPO
June 2021
phase cedar clinical trial design | Graphite Bio
Kymera
Investor Presentation
August 2023
objectives a a | Kymera
MaxCyte
Investor Presentation
October 2023
enabled active clinical trials | MaxCyte
MaxCyte
Investor Presentation
March 2023
enabled active clinical trials | MaxCyte
Other recent decks by Mink Therapeutics
See all presentations (2 decks)
Investor Day
November 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights